|[July 07, 2014]
Nordic Nanovector: Listing on NOTC
OSLO, Norway --(Business Wire)--
Nordic Nanovector (the "Company") announces that its shares will be
registered in the Norwegian OTC system (NOTC) from today, 7 July 2014,
under the symbol 'NANO'. The share capital increase in connection with
the recent NOK 250 million private placement at a subscription price of
NOK 25 has been registered in the Norwegian Register of Business
Enterprises and the number of shares currently outstanding is 22,821,375.
As resolved by the Company's general meeting on 27 June 2014, the
Company will effect a subsequent repair issue of up to 2,000,000 new
shares at a subscription price of NOK 25 per share in August/September
2014. Further details will be announced in due course.
In addition as described in the Company's press release dated 27
September 2013, 1,666,666 shares will no later than 15 October 2014 be
issued to HealthCap VI L.P. at a subscription price of NOK 15 in
connection with the private placement completed in September 2013.
About Nordic Nanovector
AS Nordic Nanovector AS is a privately held company established in 2009.
The company is based in Norway and has offices and laboratories in Oslo.
The company is developing novel innovative anticancer
radioimmunotherapeutics to treat non-Hodgkin Lymphoma (NHL) and other
Betalutin™, is a pharmaceutical product candidate consisting of a
radionuclide conjugated to a tumor seeking carrier/antibody, which can
be used for irradiation of malignant metastasized tumors with minimal
damage to nearby healthy normal tissue. This technology aims to prolong
and improve the quality of life of people who suffer from non-Hodgkin
This information was brought to you by Cision http://news.cision.com
[ Back To TMCnet.com's Homepage ]